MYIA
BPTH

Mount Yale Investment Advisors’s Bio-Path Holdings Inc BPTH Stock Holding History

Mount Yale Investment Advisors’s Portfolio BPTH Stock Details BPTH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-1,268
Closed -$45.1K – 516
2023
Q2 		$45.1K Hold
1,268
– – ﹤0.01% 474
2023
Q1 		$35.2K Hold
1,268
– – ﹤0.01% 475
2022
Q4 		$38.3K Hold
1,268
– – ﹤0.01% 448
2022
Q3 		$81K Buy
+1,268
New +$96.3K 0.01% 436

Other funds holding BPTH

Walleye Capital
Walleye Capital New York $24B AUM 37.67% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SA
Strategic Advocates Logan, Utah $22.6M AUM 26.98% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
WAM
Warberg Asset Management Winnetka, Illinois $600M AUM 23.37% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Mount Yale Investment Advisors's BPTH Position: Q3 2023 in Review

Mount Yale Investment Advisors sold out of Bio-Path Holdings Inc (BPTH) in Q3 2023, closing a stake of 1,268 shares — an estimated $45.1K sold.

Mount Yale Investment Advisors first reported a position in BPTH in Q3 2022 and held it in 4 quarters. The position peaked at $81K in Q3 2022. 21 funds tracked by Wall St. Rank hold BPTH as of Q3 2023.

  • Mount Yale Investment Advisors reported no remaining Bio-Path Holdings Inc position as of Q3 2023 after selling out during the quarter.
  • Mount Yale Investment Advisors sold 1,268 Bio-Path Holdings Inc shares in Q3 2023, an estimated $45.1K.
  • Mount Yale Investment Advisors first reported a position in Bio-Path Holdings Inc in Q3 2022 and held it in 4 quarters.
  • Mount Yale Investment Advisors's Bio-Path Holdings Inc position peaked at $81K in Q3 2022.
  • 21 funds tracked by Wall St. Rank held Bio-Path Holdings Inc as of Q3 2023.

Based on Mount Yale Investment Advisors's 13F filing for Q3 2023, filed 11 Oct 2023.